Petmed Express (PETS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.18, -3.28% vs the prior close of $1.22.
- Volume 188.44K shares, 1.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PETS slides 3.3% to $1.18, a 52-week low. Closed at $1.18, -3.28% vs the prior close of $1.22. Day range $1.15–$1.22, opened at $1.21.
PETS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PETS slides 3.3% to $1.18, a 52-week low
- Closed at $1.18, -3.28% vs the prior close of $1.22. Day range $1.15–$1.22, opened at $1.21.
- Volume was 188.44K shares, 1.6x its 50-day average of 118.24K.
- Price is -27.3% vs its 50-day average ($1.62) and -46.9% vs its 200-day average ($2.22).
- 52-week range $1.15–$4.10; today's close sits at 1% of that range, 71.2% below the 52-week high.
Oct 15, 2026 — PETS rises 1.7% to $1.22
- Closed at $1.22, +1.67% vs the prior close of $1.20. Day range $1.20–$1.23, opened at $1.21.
- Volume was 50.00K shares, 0.4x its 50-day average of 117.72K — lighter than usual.
- Price is -25.6% vs its 50-day average ($1.64) and -45.4% vs its 200-day average ($2.23).
- 52-week range $1.20–$4.10; today's close sits at 1% of that range, 70.2% below the 52-week high.
Oct 14, 2026 — PETS slides 5.5% to $1.20, a 52-week low on 3.8x normal volume
- Closed at $1.20, -5.51% vs the prior close of $1.27. Day range $1.20–$1.27, opened at $1.26.
- Volume was 416.80K shares, 3.8x its 50-day average of 110.44K — unusually heavy trading.
- Price is -27.5% vs its 50-day average ($1.65) and -46.5% vs its 200-day average ($2.24).
- 52-week range $1.20–$4.10; today's close sits at 0% of that range, 70.7% below the 52-week high.
Oct 13, 2026 — PETS rises 0.8% to $1.27
- Closed at $1.27, +0.79% vs the prior close of $1.26. Day range $1.27–$1.30, opened at $1.27.
- Volume was 87.70K shares, 0.8x its 50-day average of 109.86K.
- Price is -24.0% vs its 50-day average ($1.67) and -43.7% vs its 200-day average ($2.25).
- 52-week range $1.26–$4.10; today's close sits at 0% of that range, 69.0% below the 52-week high.
Oct 12, 2026 — PETS dips 2.3% to $1.26, a 52-week low
- Closed at $1.26, -2.33% vs the prior close of $1.29. Day range $1.26–$1.29, opened at $1.27.
- Volume was 82.50K shares, 0.8x its 50-day average of 109.76K.
- Price is -25.2% vs its 50-day average ($1.68) and -44.4% vs its 200-day average ($2.27).
- 52-week range $1.26–$4.10; today's close sits at 0% of that range, 69.3% below the 52-week high.
Oct 9, 2026 — PETS rises 0.8% to $1.29
- Closed at $1.29, +0.78% vs the prior close of $1.28. Day range $1.27–$1.29, opened at $1.28.
- Volume was 31.30K shares, 0.3x its 50-day average of 109.80K — lighter than usual.
- Price is -24.1% vs its 50-day average ($1.70) and -43.3% vs its 200-day average ($2.28).
- 52-week range $1.27–$4.10; today's close sits at 1% of that range, 68.5% below the 52-week high.
Oct 8, 2026 — PETS ends flat (+0.0%) to $1.28, 10 down days in a row
- Closed at $1.28, +0.00% vs the prior close of $1.28. Day range $1.27–$1.29, opened at $1.28.
- Volume was 143.30K shares, 1.3x its 50-day average of 107.49K.
- Price is -25.3% vs its 50-day average ($1.71) and -44.1% vs its 200-day average ($2.29).
- 52-week range $1.27–$4.10; today's close sits at 0% of that range, 68.8% below the 52-week high.
- That makes 10 straight losses.
Oct 7, 2026 — PETS dips 2.3% to $1.28, a 52-week low, 9 down days in a row
- Closed at $1.28, -2.29% vs the prior close of $1.31. Day range $1.27–$1.31, opened at $1.30.
- Volume was 91.60K shares, 0.8x its 50-day average of 107.94K.
- Price is -25.9% vs its 50-day average ($1.73) and -44.3% vs its 200-day average ($2.30).
- 52-week range $1.27–$4.10; today's close sits at 0% of that range, 68.8% below the 52-week high.
- That makes 9 straight losses.
Oct 6, 2026 — PETS dips 0.8% to $1.31, a 52-week low, 8 down days in a row
- Closed at $1.31, -0.76% vs the prior close of $1.32. Day range $1.30–$1.35, opened at $1.32.
- Volume was 139.90K shares, 1.3x its 50-day average of 106.64K.
- Price is -24.8% vs its 50-day average ($1.74) and -43.3% vs its 200-day average ($2.31).
- 52-week range $1.30–$4.10; today's close sits at 0% of that range, 68.0% below the 52-week high.
- That makes 8 straight losses.
Oct 5, 2026 — PETS dips 2.9% to $1.32, a 52-week low, 7 down days in a row
- Closed at $1.32, -2.94% vs the prior close of $1.36. Day range $1.31–$1.35, opened at $1.35.
- Volume was 66.80K shares, 0.6x its 50-day average of 107.37K.
- Price is -24.8% vs its 50-day average ($1.75) and -43.2% vs its 200-day average ($2.32).
- 52-week range $1.31–$4.10; today's close sits at 0% of that range, 67.8% below the 52-week high.
- That makes 7 straight losses.
Oct 2, 2026 — PETS dips 0.7% to $1.36, a 52-week low, 6 down days in a row
- Closed at $1.36, -0.73% vs the prior close of $1.37. Day range $1.33–$1.37, opened at $1.36.
- Volume was 185.20K shares, 1.6x its 50-day average of 114.14K.
- Price is -23.1% vs its 50-day average ($1.77) and -41.8% vs its 200-day average ($2.34).
- 52-week range $1.33–$4.10; today's close sits at 1% of that range, 66.8% below the 52-week high.
- That makes 6 straight losses.
PETS latest news & SEC filings
Every SEC filing by or about PETS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Willard Jeffrey Allen received an award of 250,000 shares on Sep 28, 2026; now holds 250,000
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 28, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Sep 28, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Elkeles Tamar received an award of 49,923 shares on Sep 17, 2026; now holds 49,923
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 21, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $41.02M (prior year $51.18M) (-19.9% vs Jun 30, 2025)
- Net income: -$6.14M (prior year -$34.15M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.28 (prior year -$1.65) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.07 — Reported shareholder vote results.
Aug 12, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade PETS
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: Jun 2, 2026, Nov 13, 2025, Oct 14, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.91% (largest 7.8%).
- Liquidity: about 140.43K shares (≈$165.71K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.18 vs a range of $1.15–$4.10 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 12 open-market buys, 0 sales; latest: Zyman Stephannie Matz bought 25,000 shares on Jun 8, 2026.
- Latest filings: 8-K Sep 28, 2026; 8-K Sep 21, 2026; 8-K Sep 17, 2026.
- Share count: 21.68M shares outstanding (Aug 7, 2026), +4.9% vs a year earlier.
- Listing: Nasdaq · industry: Retail-Drug Stores and Proprietary Stores.
PETS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.21 | 1.22 | 1.15 | 1.18 | 188.44K |
| Oct 15, 2026 | 1.21 | 1.23 | 1.20 | 1.22 | 50.00K |
| Oct 14, 2026 | 1.26 | 1.27 | 1.20 | 1.20 | 416.80K |
| Oct 13, 2026 | 1.27 | 1.30 | 1.27 | 1.27 | 87.70K |
| Oct 12, 2026 | 1.27 | 1.29 | 1.26 | 1.26 | 82.50K |
| Oct 9, 2026 | 1.28 | 1.29 | 1.27 | 1.29 | 31.30K |
| Oct 8, 2026 | 1.28 | 1.29 | 1.27 | 1.28 | 143.30K |
| Oct 7, 2026 | 1.30 | 1.31 | 1.27 | 1.28 | 91.60K |
| Oct 6, 2026 | 1.32 | 1.35 | 1.30 | 1.31 | 139.90K |
| Oct 5, 2026 | 1.35 | 1.35 | 1.31 | 1.32 | 66.80K |
| Oct 2, 2026 | 1.36 | 1.37 | 1.33 | 1.36 | 185.20K |
| Oct 1, 2026 | 1.38 | 1.39 | 1.37 | 1.37 | 55.30K |
| Sep 30, 2026 | 1.38 | 1.42 | 1.36 | 1.38 | 85.80K |
| Sep 29, 2026 | 1.42 | 1.42 | 1.38 | 1.40 | 73.60K |
| Sep 28, 2026 | 1.53 | 1.53 | 1.40 | 1.41 | 275.20K |
| Sep 25, 2026 | 1.55 | 1.56 | 1.53 | 1.53 | 224.70K |
| Sep 24, 2026 | 1.55 | 1.57 | 1.55 | 1.56 | 83.70K |
| Sep 23, 2026 | 1.57 | 1.57 | 1.55 | 1.55 | 95.60K |
| Sep 22, 2026 | 1.61 | 1.61 | 1.57 | 1.57 | 114.50K |
| Sep 21, 2026 | 1.72 | 1.73 | 1.60 | 1.60 | 316.70K |
About Petmed Express
Petmed Express (PETS) is listed on the Nasdaq and classified by the SEC under “Retail-Drug Stores and Proprietary Stores”. Its business address is in DELRAY BEACH, FL. State of incorporation: FL. Fiscal year ends March 31. SEC CIK 1040130.
PETS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Peter Batushansky | Director | Aug 12, 2026 |
| Leslie C.G. Campbell | Interim CEO and President | Aug 13, 2026 |
| Tamar Elkeles | Director | Sep 21, 2026 |
| Gian Fulgoni | Director | Jan 23, 2026 |
| James Lacamp | Director | Aug 12, 2026 |
| Justin L. Mennen | Director | Aug 12, 2026 |
| Leah Solivan | Director | Nov 3, 2025 |
| Jeffrey Allen Willard | CEO and President | Sep 29, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Leslie C.G. Campbell | Interim CEO and President | Aug 13, 2026 |
| Douglas Krulik | CAO and Interim CFO | Jul 24, 2026 |
| Jeffrey Allen Willard | CEO and President | Sep 29, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 8, 2026 | Zyman Stephannie Matz | Buy | 25,000 | $1.75 |
| Jun 8, 2026 | Zyman Stephannie Matz | Buy | 25,000 | $1.75 |
| Jun 8, 2026 | Capital Holdings Inc. Nina | Buy | 25,000 | $1.75 |
| Jun 8, 2026 | Capital Holdings Inc. Nina | Buy | 25,000 | $1.75 |
| Jun 8, 2026 | Galante Moises Tache | Buy | 25,000 | $1.75 |
| Jun 8, 2026 | Galante Moises Tache | Buy | 25,000 | $1.75 |
| Jun 8, 2026 | Zyman Stephannie Matz | Buy | 25,000 | $1.75 |
| Jun 8, 2026 | Zyman Stephannie Matz | Buy | 25,000 | $1.75 |
| Jun 8, 2026 | Capital Holdings Inc. Nina | Buy | 25,000 | $1.75 |
| Jun 8, 2026 | Capital Holdings Inc. Nina | Buy | 25,000 | $1.75 |
| Jun 8, 2026 | Galante Moises Tache | Buy | 25,000 | $1.75 |
| Jun 8, 2026 | Galante Moises Tache | Buy | 25,000 | $1.75 |
PETS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Mar 31, 2026 | $179.02M | $-57.29M | -2.74 | $-28.39M |
| Mar 31, 2025 | $226.97M | $-6.27M | -0.30 | $4.72M |
| Mar 31, 2024 | $274.10M | $-7.46M | -0.37 | $4.32M |
| Mar 31, 2023 | $247.57M | $5.14M | 0.25 | $27.80M |
| Mar 31, 2022 | — | $18.72M | 0.92 | $18.50M |
Latest balance sheet: total assets $63.76M, total liabilities $40.77M, cash $13.08M (as of Jun 30, 2026).
PETS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $2.03 |
| Jun 2, 2026 | 8-K Item 2.02 (results) | $2.13 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $1.96 |
| Oct 14, 2025 | 8-K Item 2.02 (results) | $2.56 |
| Jun 16, 2025 | 8-K Item 2.02 (results) | $3.60 |
| Feb 10, 2025 | 8-K Item 2.02 (results) | $5.27 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $4.22 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| Jun 11, 2024 | 8-K Item 2.02 (results) | — |
| Apr 15, 2024 | 8-K Item 2.02 (results) | — |
| Feb 8, 2024 | 8-K Item 2.02 (results) | — |
| Oct 30, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Retail-Drug Stores and Proprietary Stores
Cvs Health (CVS)Guardian Pharmacy Services (GRDN)Ridgetech (RDGT)111 (YI)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PETS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.